Rafferty Asset Management’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-5,775
| Closed | -$277K | – | 1018 |
|
|
2020
Q1 | $277K | Sell |
5,775
-43,220
| -88% | -$2.07M | 0.01% | 459 |
|
|
2019
Q4 | $2.3M | Sell |
48,995
-48,988
| -50% | -$2.3M | 0.04% | 342 |
|
|
2019
Q3 | $2.32M | Buy |
97,983
+22,891
| +30% | +$541K | 0.04% | 310 |
|
|
2019
Q2 | $2.26M | Buy |
75,092
+31,696
| +73% | +$953K | 0.04% | 365 |
|
|
2019
Q1 | $972K | Buy |
+43,396
| New | +$972K | 0.02% | 556 |
|